Related Experiment Video
Updated: May 8, 2026

11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
"1 + 1 = 3": The Added Value of Combining Immunohistochemistry and Dual-Probe Chromogen In Situ Hybridization to
Valentina Angerilli1, Alessandro Gambella2, Simona Pigozzi2
1Department of Medicine (DIMED), University of Padua, Padua, Italy; Surgical Pathology Unit, ULSS2 Marca Trevigiana, Treviso, Italy.
Abstract
No abstract available in PubMed .

